Is nan entity falling for DexCom (NASDAQ: DXCM)? Shares of nan aesculapian instrumentality master dropped disconnected a cliff pursuing its second-quarter net report. Unfortunately, nan diabetes-focused institution grounded to impressment investors yet again pinch its astir caller quarterly update.
At astir $69…
This communicative appeared connected aol.com, 2024-11-08 15:55:36.462000.